CRISPR Therapeutics AG (NASDAQ:CRSP)

56.76
Delayed Data
As of 4:00pm ET
 -1.35 / -2.32%
Today’s Change
30.75
Today|||52-Week Range
74.00
-6.81%
Year-to-Date
Better Buy: Vertex Pharmaceuticals vs. Incyte
Feb 19 / MotleyFool.com - Paid Partner Content
First CRISPR Gene Editing Trial in Cancer Patients Shows Promising Results
Feb 07 / MotleyFool.com - Paid Partner Content
CRISPR Therapeutics Reports Q4 Earnings, Beats Revenue Expectations
Feb 12 / MotleyFool.com - Paid Partner Content
If You Invested $100 in CRISPR Therapeutics' IPO, This Is How Much Money You'd Have Now
Feb 07 / MotleyFool.com - Paid Partner Content